Mice Cured of Diabetes with Beta Cell Transplant

     A new technique for growing pancreatic cells and stem cells has allowed phenomenal results in the treatment of severe diabetes in rodents. Two weeks after therapy, blood sugar levels returned to normal and remained so for nine months.

     In diabetes mellitus, the pancreatic beta cells do not produce enough or even stop producing insulin. As a result, patients themselves have to inject it into the blood themselves. In recent years, scientists have been actively developing an alternative approach using stem cells.

     Researchers at the School of Medicine at George Washington University confirm the effectiveness of such a technique, at least in mice. They published the results of their research in the journal Nature Biotechnology.

     Despite such successes, the results obtained in mice cannot be automatically transferred to humans, says Dr. Jeffrey R. Millman, associate professor of medical and biomedical engineering at J. Washington University.

     Therefore, before starting clinical experiments on people, it is necessary to test them on larger animals for a longer time. It is necessary to automate the process of obtaining beta cells, he said.

     Diabetes mellitus is an endocrine disease associated with impaired glucose uptake and developing due to insulin deficiency. The disease is characterized by a chronic course and a violation of all types of metabolism in the body.

Post a Comment